In a new research study, more than 900 people from around the world explain the challenges and benefits of microdosing LSD and psilocybin-containing mushrooms.
Thomas Durcan's lab is growing 3D mini-brains in the search for a cure for Parkinson's disease. Over the next year he is giving all his lab's protocols, methods and results away.
According to new research, individuals who take small regular doses of psychedelics such as LSD and psilocybin mushrooms score higher on mental health, well-being and creativity.
To know the real promise of psychedelic substances like LSD, mushrooms and MDMA, researchers must embrace the principles and practise of 'open science.'
In our institutions of higher education and our research labs, scholars first produce, then buy back, their own content. With the costs rising and access restricted, something's got to give.
Partly in response to the so-called 'reproducibility crisis' in science, researchers are embracing a set of practices that aim to make the whole endeavor more transparent, more reliable – and better.